Specify a stock or a cryptocurrency in the search bar to get a summary
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
2TZTianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; and biochemical pharmaceutical products, as well as wholesale and retail sale of medicines. Its products include Suxiao Jiuxin Pills, Jingwanhong Ointment, Biqi Capsules, Shunaoxin Dropping Pills, Zilongjin Tablets, Qingfei Xiaoyan Pills, Huoxiangzhengqi Soft Capsules, Tongmai Yangxin Pills, Weichangan Pills, Qingyan Dropping Pills, Haima Bushen Pills, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Qinggong Shoutao Pills, etc. The company also engages in pharmaceutical commercial logistic services; pharmaceuticals retail; chemical raw materials and preparations; and biomedicine. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was founded in 1981 and is based in Tianjin, the People's Republic of China. Address: Darentang Building, Tianjin, China, 300193
Analytics
WallStreet Target Price
–P/E ratio
14.9833Dividend Yield
7.5 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 2TZ
Dividend Analytics 2TZ
Dividend growth over 5 years
418 %Continuous growth
6 yearsPayout Ratio 5 years average
7 %Dividend History 2TZ
Stock Valuation 2TZ
Financials 2TZ
Results | 2019 | Dynamics |